ArticleInternational journal of analytical chemistry2026
A Stability-Indicating RP-HPLC Method for Simultaneous Determination of Triclabendazole and Levamisole in Oral Suspension Formulation.
Article in International journal of analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Stability-Indicating RP-HPLC Method for Simultaneous Determination of Triclabendazole and Levamisole in Oral Suspension Formulation.International journal of analytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A fast, simple, and precise stability-indicating high-performance liquid chromatographic (HPLC) method was developed for analysis of triclabendazole (TBZ) and levamisole (LEV) in oral suspension. Using a mobile phase composed of acetonitrile, methanol, and water (50:40:10, v/v/v), with the pH adjusted to 4.6 with 0.1 M phosphoric acid. The mobile phase was filtered, degassed, and pumped at a flow rate of 1.0 mL/min. Detection was performed at 245 nm. The proposed method was validated with respect to specificity, linearity, limit of detection (LOD) and limit of quantification (LOQ), interday and intraday precision, robustness, and accuracy. The retention times for TBZ and LEV were found to be about 3.116 and 1.385 min, respectively. Calibration plots were linear with correlation coefficient of 0.9999 in the concentration range of 200-800 and 150-600 μg/mL for TBZ and LEV, respectively. The method was verified to be stability indicating by separating the active ingredients from their stressed testing degradation products. The procedure proved acceptable robustness to variations in flow rate, wavelength, and column temperature. The method was conveniently used for the analysis of TBZ and LEV in oral suspension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.